CCL17 was also noted to be an important biomarker for eosinophilic disorders including differentiating eosinophilic pneumonia from acute lung injury (Miyazaki et al. 2007; Catherine and Roufosse 2021). This evidence concerns the gene CCL17 and eosinophilic pneumonia.